- Home
- KURA vs IMOS Comparison
KURA vs IMOS Comparison
Compare KURA & IMOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- IMOS
- Stock Information
- Founded
- KURA 2014
- IMOS 1997
- Country
- KURA United States
- IMOS Taiwan
- Employees
- KURA N/A
- IMOS N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- IMOS Semiconductors
- Sector
- KURA Health Care
- IMOS Technology
- Exchange
- KURA Nasdaq
- IMOS Nasdaq
- Market Cap
- KURA 561.9M
- IMOS 580.7M
- IPO Year
- KURA N/A
- IMOS N/A
- Fundamental
- Price
- KURA $7.34
- IMOS $16.03
- Analyst Decision
- KURA Strong Buy
- IMOS
- Analyst Count
- KURA 13
- IMOS 0
- Target Price
- KURA $24.45
- IMOS N/A
- AVG Volume (30 Days)
- KURA 1.5M
- IMOS 20.1K
- Earning Date
- KURA 08-07-2025
- IMOS 08-12-2025
- Dividend Yield
- KURA N/A
- IMOS 4.00%
- EPS Growth
- KURA N/A
- IMOS N/A
- EPS
- KURA N/A
- IMOS 0.01
- Revenue
- KURA $83,279,000.00
- IMOS $777,452,000.00
- Revenue This Year
- KURA $125.04
- IMOS $3.12
- Revenue Next Year
- KURA $83.75
- IMOS $3.25
- P/E Ratio
- KURA N/A
- IMOS $95.80
- Revenue Growth
- KURA N/A
- IMOS 0.89
- 52 Week Low
- KURA $5.41
- IMOS $12.78
- 52 Week High
- KURA $21.57
- IMOS $23.85
- Technical
- Relative Strength Index (RSI)
- KURA 67.38
- IMOS 31.77
- Support Level
- KURA $5.45
- IMOS $17.14
- Resistance Level
- KURA $6.74
- IMOS $18.00
- Average True Range (ATR)
- KURA 0.38
- IMOS 0.40
- MACD
- KURA 0.10
- IMOS -0.10
- Stochastic Oscillator
- KURA 82.17
- IMOS 1.00
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
About IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.